SPEEDGEL RX

Manufacturer
Gensco Laboratories, LLC | All Pharma LLC
Effective date
2022-10-05
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-06-01 02:18:15

Label at a glance#

ProductSPEEDGEL RX
Active ingredientECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, ACONITUM NAPELLUS, ARNICA MONTANA, CALENDULA OFFICINALIS FLOWERING TOP, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, ATROPA BELLADONNA, BELLIS PERENNIS, CHAMOMILE, ACHILLEA MILLEFOLIUM, HYPERICUM OIL, COMFREY ROOT, COLCHICINE, GINGER
Label structure14 sections

Indications and uses

SpeedGel Rx® is indicated for the relief of pain, inflammation and bruising from musculoskeletal pain and associated inflammation, inflammatory conditions of joints and soft tissues, arthritis, injuries such as sprains, strains, and disclocations, repetitive/overuse injuries, general aches and pains, contusions and trauma to such areas as hands, wrist, elbow, shoulder, neck, back, knees, ankles, feet and toes.

Dosage and administration

Apply 1 ml (4 pumps of the bottle) as a thin layer to the affected area 3-4 times daily and rub in gently (wash hands after application). Applications of less than 3-4 times daily will not produce optimum results. Excess amounts may be wiped from the area. Safe to use on children over the age of 2 years. Applications of less than 3-4 times a day will not produce optimum results. Excess drops may be wiped from the ...

Storage and handling

NDC 35781-0210-1 HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL RX ONLY NET CONTENTS 0.33 FL OZ (10 ML) Package Size: 0.33 fl oz (10ml) bottle NDC 35781-0210-2 HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL RX ONLY NET CONTENTS 1.01 FL OZ (30 ML) Package Size: 1.01 fl oz (30ml) bottle NDC 35781-0210-9 HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL RX ONLY NET CONTENTS 3.04 FL OZ (90 ML) Package Size: 3.04 fl oz (90ml) bottle Manufactu...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

SpeedGel Rx® is a prescription transdermal gel that provides relief of pain, inflammation and bruising, utilizing patented Isopeutic™
Transdermal Technology. The Gensco® patented transdermal drug delivery system used in SpeedGel Rx® carries proprietary formulation of
active ingredients, through the skin to the locally affected tissues. SpeedGel Rx® is applied directly to the affected site specifically,
minimizing side effects, interactions and comorbidities caused by oral
therapies and topical NSAIDs. Furthermore, SpeedGel Rx® is clinically
proven to reduce narcotic use.


SpeedGel Rx® is indicated for the relief of pain, inflammation and bruising from musculoskeletal pain and associated inflammation, inflammatory conditions of joints and soft tissues, arthritis, injuries such as sprains, strains, and disclocations, repetitive/overuse injuries, general aches and pains, contusions and trauma to such areas as hands, wrist, elbow, shoulder, neck, back, knees, ankles, feet and toes. SpeedGel Rx® is a proprietary combination of 14 active ingredients, 4 of which are prescription, in a patented transdermal delivery system. Among the prescription ingredients is Colchicinum Autumnale also known as Colchicine, which is a well-known, strong and effective anti-inflammatory medication.


It contains the following active ingredients:
Aconitum Napellus 3X HPUS, Arnica Montana 1X HPUS, Belladonna 3X
HPUS, Bellis Perennis 1X HPUS, Calendula Officinalis 1X HPUS,
Chamomilla 1X HPUS, Colchicinum 3X HPUS, Echinacea Angustifolia
1X HPUS, Echinacea Purpurea 1X HPUS, Hamamelis Virginiana 1X
HPUS, Hypericum Perforatum 1X HPUS, Millefolium 1X HPUS,
Symphytum Officinale 3X HPUS, Zingiber Officinale 1X HPUS.

It also contains the following inactive ingredients:
Docusate sodium, Ethyl Alcohol, Isopropyl myristate, Lecithin, Purified
Water & Urea.


The patented transdermal gel’s liposomal base comprising of hydrophilic and lipophilic components is designed to suspend the active ingredients and allow for the hydration of the skin barrier and movement of the active ingredients, irrespective of their molecular polarity, across the skin at an enhanced rate. The unique transdermal characteristics in SpeedGel Rx® permit the active ingredients to penetrate to the site of injury, diminishing pain and inflammation, and enhancing bruise resolution. As a topically applied transdermal medication,  SpeedGel Rx® avoids the common concerns of toxicity and drug interactions associated with systemic (oral) medications.


SpeedGel Rx® is an amber colored, odorless gel dispensed in a patented metered dose container (MDose) containing either 10ml, 30ml, or 90ml. Gensco’s unique metered dose technology (MDose™) which dispenses exactly (0.25 mL of medication per pump) per application, covering a 2”x2” area of skin. MDose provides more accurate dosing, less waste and significant cost savings (Gensco® Pharma Tube vs. Pump Study).

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

SpeedGel Rx® is a drug under FDA regulation and HPUS monograph. The active ingredients of SpeedGel Rx® are listed and described within
the Homeopathic Pharmacopeia of the United States (HPUS), the official FDA compendium of homeopathic drugs.

The Homeopathic Pharmacopeia of the United States (HPUS), the officially recognized FDA reference source for homeopathic compounds
in the U.S., identifies the ingredients of SpeedGel Rx® as shown in TABLE 1.:

Ingredients Common NameIndications

Aconitum Napellus

Monk’s-hood

Neuralgia, rheumatism,

hemostasis, analgesia

Arnica Montana

Mountain arnica

Stimulates healing of injured

tissues, wounds, contusions,

hematomas, neuralgia, myalgia,

analgesia

Belladonna

Deadly nightshade

Inflammation locally

Bellis Perennis

Daisy

Dislocations, bruising,

reducing edema

Calendula Officinalis

Calendula

Analgesia, inflammation

Colchicinum

Colchicine

Inflammation and gout

Chamomilla

Chamomile

Inflammation, promotes

healing of tissues

Echinacea Angustifolia

Narrow leaf cone flower

Inflammation and inhibits

hyaluronidase

Echinacea Purpurea

Purple cone flower

Stimulates fibroblasts,

inflammation

Hamamelis Virginiana

Witch-hazel

Astringent, analgesic, hematomas

Hypericum Perforatum

St. John’s wort

Neuropathic pains

Millefolium

Yarrow

Hematomas, wound healing

Symphytum Officinale

Comfrey

Neuropathy, causalgia,

contusions, periostitis

Zingiber Officinale

Ginger

Inflammation

Bolded items are at strengths recognized by the HPUS as requiring a prescription.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

SpeedGel Rx® is indicated for the relief of pain, inflammation and bruising from musculoskeletal pain and associated inflammation,
inflammatory conditions of joints and soft tissues, arthritis, injuries such as sprains, strains, and disclocations, repetitive/overuse injuries, general aches and pains, contusions and trauma to such areas as hands, wrist, elbow, shoulder, neck, back, knees, ankles, feet and toes.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Known sensitivity to any of the active or inactive ingredients of SpeedGel Rx®.

WARNINGS

WARNINGS SECTION

For external use only. Direct patient not to ingest SPEEDGEL RX and to avoid contact with the eyes and mucous membranes, wounds, and damaged skin. If condition worsens, or if symptoms persist for more than seven days or clear up and occur again within a few days, patient should consult a doctor. If a rash develops, patient should discontinue use until rash clears. After the disappearance of rash, patient can try SPEEDGEL RX again on a test area and monitor the site for additional results. If no rash or redness results, then patient can resume use. However, if the rash persists or redevelops, use should be discontinued.


Direct patient to keep this product out of reach of children and seek medical help or contact a Poison Control Center immediately if swallowed.

PRECAUTIONS

PRECAUTIONS SECTION

Use in Pregnancy: No human or animal studies on the effect of SPEEDGEL RX in pregnancy have been conducted.

Nursing Mothers: It is not known whether SPEEDGEL RX is excreted in breast milk.

FEMALES & MALES OF REPRODUCTIVE POTENTIAL

FEMALES & MALES OF REPRODUCTIVE POTENTIAL SECTION

No human or animal studies on the effect of SpeedGel Rx® in females & males of reproductive potential have been conducted.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Rarely, allergic skin reactions may occur. If allergic reactions occur, discontinue use of the drug.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Apply 1 ml (4 pumps of the bottle) as a thin layer to the affected area 3-4 times daily and rub in gently (wash hands after application). Applications of less than 3-4 times daily will not produce optimum results. Excess amounts may be wiped from the area. Safe to use on children over the age of 2 years.

Applications of less than 3-4 times a day will not produce optimum results. Excess drops may be wiped from the area.

HOW SUPPLIED/STORAGE AND HANDLING

HOW SUPPLIED SECTION

NDC 35781-0210-1 HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL RX ONLY NET CONTENTS 0.33 FL OZ (10 ML) Package Size: 0.33 fl oz (10ml) bottle NDC 35781-0210-2 HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL RX ONLY NET CONTENTS 1.01 FL OZ (30 ML) Package Size: 1.01 fl oz (30ml) bottle NDC 35781-0210-9 HOMEOPATHIC TRANSDERMAL PAIN RELIEF GEL RX ONLY NET CONTENTS 3.04 FL OZ (90 ML) Package Size: 3.04 fl oz (90ml) bottle Manufactured for: Manufactured for: Gensco Pharma, LLC 8550 NW 33rd Street, Suite 200. Miami, FL 33122 (855) 743-6726 www.genscopharma.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Box-10mL
Box-10mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Box-30mL
Box-30mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Box-90mL
Box-90mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label
Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
51989a2b-944a-b31f-835e-469c133570adProduct name220250716
11e940b0-77bd-45d4-a80f-028ff6bd67e2Product name220250214
14efe2b0-2695-4943-8b2f-24f519c99fedProduct name120231023
bf4e8ffd-8f13-3050-5248-581676b7ea42Product name620221214
987af351-b977-4822-ac44-c76d29e24e78Product name120190611

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
35781-0210-1SPEEDGEL RX1 in 1 CARTONGEL18
35781-0210-1SPEEDGEL RX10 mL in 1 BOTTLE, DISPENSINGGEL108
35781-0210-2SPEEDGEL RX1 in 1 CARTONGEL18
35781-0210-2SPEEDGEL RX30 mL in 1 BOTTLE, DISPENSINGGEL308
35781-0210-9SPEEDGEL RX1 in 1 CARTONGEL18
35781-0210-9SPEEDGEL RX90 mL in 1 BOTTLE, DISPENSINGGEL908

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
35781-0210SPEEDGEL RX (ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, ACONITUM NAPELLUS, ARNICA MONTANA, CALENDULA OFFICIANALIS, HAMAMELIS VIRGINIANA, BELLADONNA, BELLIS PERENNIS, CHAMOMILLIA, MILLEFOLIUM, HYPERICUM PERFORATUM, SYMPHYTUM OFFICINALE, COLCHICINUM, ZINGIBER OFFICINALE) GEL [GENSCO LABORATORIES, LLC]8Legacy NDC, 6 package rows20221007_abc4b132-4d35-46a4-9a8e-9bd4c7a0f4b0.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
35781-0210-1ML - Milliliter35781-021011a97c98-f8ca-4730-b7ad-18e5c84f19b412013-02-13
35781-0210-2ML - Milliliter35781-0210cd484876-f4a4-4c51-9801-04b6418d1f3312013-02-13
35781-0210-9ML - Milliliter35781-02106aab4839-0147-4103-a899-6bbf99c905f712015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ACHILLEA MILLEFOLIUMACTIVE INGREDIENT2FXJ6SW4PK3
ACONITUM NAPELLUSACTIVE INGREDIENTU0NQ8555JD3
ARNICA MONTANAACTIVE INGREDIENTO80TY208ZW3
ATROPA BELLADONNAACTIVE INGREDIENTWQZ3G9PF0H3
BELLIS PERENNISACTIVE INGREDIENT2HU33I03UY3
CALENDULA OFFICINALIS FLOWERING TOPACTIVE INGREDIENT18E7415PXQ3
CHAMOMILEACTIVE INGREDIENTFGL3685T2X3
COLCHICINEACTIVE INGREDIENTSML2Y3J35T3
COMFREY ROOTACTIVE INGREDIENTM9VVZ08EKQ3
ECHINACEA ANGUSTIFOLIAACTIVE INGREDIENTVB06AV5US83
ECHINACEA PURPUREAACTIVE INGREDIENTQI7G114Y983
GINGERACTIVE INGREDIENTC5529G5JPQ3
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARKACTIVE INGREDIENTT7S323PKJS3
HYPERICUM OILACTIVE INGREDIENTOZU2FC70HY3
ACHILLEA MILLEFOLIUMACTIVE MOIETY2FXJ6SW4PK3
ACONITUM NAPELLUSACTIVE MOIETYU0NQ8555JD3
ARNICA MONTANAACTIVE MOIETYO80TY208ZW3
ATROPA BELLADONNAACTIVE MOIETYWQZ3G9PF0H3
BELLIS PERENNISACTIVE MOIETY2HU33I03UY3
CALENDULA OFFICINALIS FLOWERING TOPACTIVE MOIETY18E7415PXQ3
CHAMOMILEACTIVE MOIETYFGL3685T2X3
COLCHICINEACTIVE MOIETYSML2Y3J35T3
COMFREY ROOTACTIVE MOIETYM9VVZ08EKQ3
ECHINACEA ANGUSTIFOLIAACTIVE MOIETYVB06AV5US83
ECHINACEA PURPUREAACTIVE MOIETYQI7G114Y983
GINGERACTIVE MOIETYC5529G5JPQ3
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARKACTIVE MOIETYT7S323PKJS3
HYPERICUM OILACTIVE MOIETYOZU2FC70HY3
DOCUSATE SODIUMINACTIVE INGREDIENTF05Q2T2JA03
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS3
LECITHIN, SOYBEANINACTIVE INGREDIENT1DI56QDM623
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I3
UREAINACTIVE INGREDIENT8W8T17847W3
WATERINACTIVE INGREDIENT059QF0KO0R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
35781-021035781-0210-2, 35781-0210-1, 35781-0210-9

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 217 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
UREAUREA8W8T17847WINSERT / VAGINAL50 mgExact identifier — unii candidate
7 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM, EXTENDED RELEASE / TRANSDERMAL0.85 mgExact identifier — unii candidate
174 equally ranked IID candidates
UREAUREA8W8T17847WSYSTEM / TOPICAL840 mgExact identifier — unii candidate
7 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0SUSPENSION, EXTENDED RELEASE / ORAL0.77 mgExact identifier — unii candidate
11 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRA-AMNIOTICADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGEL, METERED / TRANSDERMAL350 mgExact identifier — unii candidate
174 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSAEROSOL, FOAM / TOPICAL144 mgExact identifier — unii candidate
18 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRAVENOUS456 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRAVASCULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRADERMALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISWAB / TOPICAL0.01 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0CAPSULE / ORAL8.2 mgExact identifier — unii candidate
11 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR0.35 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSSUSPENSION / AURICULAR (OTIC)0.02 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSOIL / TOPICAL213 mgExact identifier — unii candidate
18 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / SOFT TISSUEADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSAEROSOL, SPRAY / TOPICAL6.89 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARYADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
LECITHIN, SOYBEANSOYBEAN LECITHIN1DI56QDM62POWDER, FOR SUSPENSION / ORAL39 mgExact identifier — unii candidate
7 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / EPIDURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0INJECTION / INTRAMUSCULAR0.02 %w/vExact identifier — unii candidate
11 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / NASAL20 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICAPSULE / ORAL60 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR27 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
DOCUSATE SODIUMDOCUSATE SODIUMF05Q2T2JA0TABLET / ORAL50 mgExact identifier — unii candidate
11 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IENEMA / RECTAL0.44 %v/vExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IEMULSION / OPHTHALMIC0.02 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / IRRIGATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICAPSULE, COATED PELLETS / ORAL0.01 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR7.01 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION / ENDOTRACHEALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPOWDER / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IAEROSOL, METERED / RESPIRATORY (INHALATION)ADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ILIQUID / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSFILM, EXTENDED RELEASE / TRANSDERMAL20.4 mgExact identifier — unii candidate
18 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAMUSCULAR78 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRATUMORADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS136.55 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISPRAY, METERED / NASALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION, CONCENTRATE / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPOWDER, FOR SUSPENSION / ORAL9 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / DENTALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IEMULSION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRAVITREALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ILIQUID / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICREAM / VAGINAL0.19 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSSYSTEM / TRANSDERMAL113 mgExact identifier — unii candidate
18 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ea4e4eac-3e35-5370-e053-2995a90a9cababc4b132-4d35-46a4-9a8e-9bd4c7a0f4b02022-10-05Warnings, Adverse reactionsExact identifier
spl id: ea4e4eac-3e35-5370-e053-2995a90a9cab
spl set id: abc4b132-4d35-46a4-9a8e-9bd4c7a0f4b0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.